The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Retired NBA All-star revealed that he had kidney cancer and had to get 40% of his kidney removed after going in for ...

Discover how food ads during NFL games can affect heart health, emphasizing the need for dietary management in individuals ...

Kwabena Mintah Akandoh, Minister-designate for Health, says the Mahama-led National Democratic Congress (NDC) administration ...

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...

A study that reviews the sodium and nutritional content of foods promoted during timeouts and halftime found that adults may ...

Comprehensive study exposes critical health risks of obesity, including diabetes, heart disease, and cancer, while offering ...

Research from Saint Louis University (SLU) and the University of Nevada, Reno School of Medicine finds that some of the ...